Faculty: Ridwan Shabsigh, MD

Ridwan Shabsigh, MD
Associate Professor of Urology, Columbia University
Director, New York Center of Human Sexuality
Department of Urology
Columbia-Presbyterian Medical Center
The Atchley Pavilion, 11th floor
161 Fort Washington Avenue
New York, NY 10032
email: RShabsigh@urology.columbia.edu

Sexual health is the portal to men's health

Biographical sketch:

Ridwan Shabsigh, MD, is Associate Professor of Urology at the College of Physicians & Surgeons of Columbia University in New York and attending physician at New York Presbyterian Hospital. In addition, he is the Director of the New York Center for Human Sexuality. Dr. Shabsigh received his medical degree from Damascus University Medical School in Damascus, Syria. He completed a residency and fellowship in urology at Baylor College of Medicine, Houston, Texas.

Dr. Shabsigh has focused his research on the treatment of sexual dysfunction as well as the role of sexual dysfunction in hypertension, depression, hypogonadism and the metabolic syndrome. He has participated in numerous trials on agents used in the treatment of erectile dysfunction (ED), premature ejaculation, hypogonadism and female sexual dysfunction, and he has served as an investigator for efficacy and safety trials on a variety of new medications in patients with sexual dysfunctions. A frequent contributor to the medical press, Dr. Shabsigh has authored many original papers and abstracts in addition to review articles, book chapters, and editorials. Most recently, he published a comprehensive book on ED: Back to Great Sex: Overcome ED and Reclaim Lost Intimacy.

Dr. Shabsigh is a Fellow of the American College of Surgeons and a Diplomate of the American Board of Urology, and is an active member of several organizations, including the American Urological Association, the International Society of Sexual Medicine, and the Society for Basic Urologic Research. He is also a member of the Sexual Health Council of the American Foundation of Urologic Disease and a member of the board of directors of the Sexual Medicine Society of North America. Among his editorial responsibilities, Dr. Shabsigh serves as a reviewer of the Journal of Urology and Urology. Awards he has received include the John K. Lattimer Award for Excellence in Clinical Instruction.

Curriculum vitae:

Academic training:

1970-1976 Damascus University Medical School Damascus, Syria
Aug 12, 1976 MD degree Damascus University Medical School, Damascus, Syria

Licensure:

1986 Oklahoma
1990 New York
1996 New Jersey

Traineeship:

1976-1978 Resident (surgery) Damascus University Hospitals Damascus, Syria
1979-1983 Resident (urology) Seepark Hospital Bremerhaven, Germany
1984-1987 Fellow (urology) Department of Urology Baylor College of Medicine, Houston, TX (Dr. F. Brantley Scott's fellowship in urodynamics and genitourinary prostheses)
1987-1990 Resident (urology) Baylor College of Medicine, Houston, TX

Board certification:

1992 American Board of Urology (diplomate)
2000 American Board of Urology (recertified until 2012)
1983 German "Specialist in Urology" (Facharzt fuer Urologie) certification

Professional societies:

1990 American Urological Association
1987 American Medical Association
1991 Society for Basic Urologic Research
1991 American College of Surgeons (Fellow)
1993 International Society of Sexual Medicine
1993 American Urological Association, New York Section
1993 New York Academy of Medicine
1994 Sexual Medicine Society of North America (founding member)
1995 Societe Internationale d'Urologie
1995 Society of University Urologists
1996 National Arab American Medical Society
1996 Ecuadorian Urological Society
1999 Member, Sexual Health Council, American Foundation of Urologic Disease
2003 Member, Research Council, American Urological Association
2004 Member, Board of Directors, Sexual Medicine Society of North America
2004 Member, Board of Directors, International Society for the study of Women Sexual Health
2005 Co-Chairman, Consortium for the Improvement of Erectile Function (CIEF) (CME initiative)

Academic appointments:

1990-1991 Instructor in Urology Columbia University New York, NY
1991-1998 Assistant professor of urology Columbia University New York, NY
1998-present Associate professor of urology Columbia University New York, NY

Hospital appointments:

1990-1998 Assistant attending NY Presbyterian Hospital New York, NY
1998-present Associate attending NY Presbyterian Hospital New York, NY
1990-1996 Attending Helen Hayes Hospital West Haverstraw, NY
2004-present Attending Hackensack Medical Center Hackensack, NJ

Honors:

1989 Harry Spence Resident Prize Essay Contest of the Texas Urological Society
1991 John K. Lattimer Award for Excellence in Clinical Instruction, Columbia University
2004 International Society of Sexual Medicine female sexual dysfunction prize

Grant support:

1993-1994 American Foundation of Urologic Disease (AFUD) young investigator award: Effects of denervation and reinnervation on neurotrophins in the rat penis.
1994-1995 Renewal of American Foundation of Urologic Disease (AFUD) young investigator award: Effects of denervation and reinnervation on neurotrophins in the rat penis.
1992-1993 Upjohn clinical trial: investigator. Long term safety study with Aprostadil Sterile Powder (PGE-1) (Aprostadil S. Po.) in patients with erectile dysfunction.
1993-1994 Vivus clinical trial: investigator. Program for treatment of erectile dysfunction with the medicated urethral system for erection (MUSE).
1993-1994 Schwartz-Pharma clinical trial: investigator. Dose-titration efficacy & safety study of alprostadil alphadex for erectile dysfunction in diabetics and non-diabetics followed by open label treatment.
1993-1994 Syntex clinical trial: investigator. randomized double-blind placebo controlled parallel study to assess the efficacy and safety of 4 oral dose levels of RS-15385 in men with erectile disorders.
1994-1995 Pentech clinical trial: Principal investigator. Apomorphine HC1, USP sublingual tablet escalating dose tolerance study for the treatment of psychogenic male erectile dysfunction.
1994-1995 Vivus clinical trial: Principal investigator. Double-blind, evaluation of the safety and efficacy of alprostadil for the treatment of erectile dysfunction delivered the medicated urethral system for erection (MUSE).
1994-1995 Vivus clinical trial: investigator. One year open-label evaluation of alprostadil for treatment of erectile dysfunction delivered with the medicated urethral system for erection (MUSE).
1995-1996 Pfizer clinical trial: investigator. Double blind, randomized, placebo controlled, parallel group, fixed dose, multicenter study to assess the efficacy and safety of sildenafil (UK-92,480) administered over 6 months to male patients with erectile dysfunction.
1996-1997 TAP clinical trial: investigator. Phase III, double blind, randomized, parallel group, 2-cross over, safety and efficacy study of apomorphine SL 2,4, and 6 mg sublingual tablets compared to placebo tablets for the treatment of erectile dysfunction
1996-1997 Pentech clinical trial: investigator. Oral paroxetine for the treatment of premature ejaculation.
1997-1998 Pfizer clinical trial: Principal investigator. A randomized double-blind study (with open-label treatment extension) to evaluate the efficacy and safety of Viagra in men with symptoms of depression and erectile dysfunction.
1997-1998 TAP clinical trial: investigator. Phase III, efficacy and safety study comparing escalating doses of apomorphine SL tablets to 2 doses (5 mg and 6 mg) of apomorphine SL tablests or placebo in the treatment of erectile dysfunction.
1998-1999 TAP clinical trial: investigator. Efficacy and safety study of apomorphine SL tablets comparing a doses 5 mg of apomorphine SL tablests to placebo in the treatment of erectile dysfunction in post radical prostatectomy patients.
1998-1999 Machrochem clinical trial: Investigator: Efficacy and safety study of prostaglandin E-1 gel for the treatment of erectile dysfunction
1998-1999 Schwartz-Pharma clinical trial: Principal investigator. A comparative multi-center randomized cross- over study of the efficacy and safety of alprostadil alfadex (Edex/Viridal) versus intraurethral alprostadil (MUSE) in the treatment of erectile dysfunction.
1998-1999 Schwartz-Pharma clinical trial: Principal investigator. Multi-center, open-label study of the efficacy and safety of alprostadil alfadex (Edex/Viridal) for the treatment of erectile dysfunction in patients who failed sildenafil (Viagra).
1998-1999 Pharmacia & Upjohn clinical trial: Multi-center, open-label study of the efficacy and safety of alprostadil sterile powder (Caverject) for the treatment of erectile dysfunction in patients who failed sildenafil (Viagra).
1999-2000 Pentech clinical trial: Principal investigator: Multi-center, randomized, placebo-controlled, double-blind, dose-ranging study of Apomorphine, SL for the treatment of female sexual dysfunction.
2000-2001 Lilly-ICOS clinical trial: Investigator. Efficacy and safety study of IC351 (Cialis) tablets in the treatment of erectile dysfunction.
2000-2001 Bayer clinical trial: Investigator. Efficacy and safety study of Vardenafil tablets in the treatment of erectile dysfunction in diabetic patients.
2000-2001 Bayer clinical trial: Investigator. Efficacy and safety study of Vardenafil tablets in the treatment of erectile dysfunction in post radical prostatectomy patients.
2000-2001 Lilly-ICOS clinical trial: Investigator. Efficacy and safety study of IC351 (Cialis) tablets in the treatment of erectile dysfunction.
2000-2002 Partnership in Women’s Health award: Investigator: localization of the site of action of testosterone in the female brain.
2002-2004 Boehringer Ingelheim: Investigator: Randomized, double blind, placebo controlled trial of safety and efficacy of flibanserin in females with hypoactive sexual desire disorder.
2002-2004 Bayer/GSK investigator: Depression related improvement with Vardenafil for erectile dysfunction.
2004-2005 Pfizer premature ejaculation project
2004-2005 Guilford Pharmaceuticals radical prostatectomy erectile dysfunction prevention trial
2005-2006 J&J: Investigator: Double blind placebo controlled randomized study of dapoxetine in men with premature ejaculation using vibratory threshold stimulation
2005-2006 AMS: Investigator: Surgical prosthesis outcomes evaluation study
2005-2006 Ion Channel: Investigator: phase I, double blind placebo controlled randomized study of Maxi K+ channel openers gene insertion into the penis in men with vasculogenic erectile dysfunction.

Departmental, Hospital & University Committees:

1991-1995 Urology representative, Staff committee of the Columbia-Presbyterian Medical Center, New York.
1992-1996 Urology representative, Utilization Review Committee of the Columbia-Presbyterian Hospital.
1993-present Urology representative, Columbia-Presbyterian Hospital Task Force on endoscopy.
1993-1996 Director, departmental residency education committee.
1993-present Departmental annual visiting professor coordinator.
1994-present Columbia-Presbyterian Eastside Board of directors.
1995-present Departmental task force on computerized patient record “Paperless Doctor’s Office”
1997-present Director, international urology project
2004-2005 Director, Department of Urology Finance Committee
2004-present Member, Office of CME advisory committee
2005-present Member, Department of Urology Faculty Compensation Committee

Teaching experience & responsibilities:

97-present Lecturer Annual sexual anatomy and physiology lecture to 1st year medical students Alumni auditorium
03-present Lecturer Biweekly human sexuality lecture for the 3rd year urology rotation clerkship
6/86 Moderator Annual Meeting German Urological Congress Bremerhaven, Germany
9/87 Faculty Ultrasonography in Urology, AUA seminar San Diego, CA
6/91 Guest faculty Baylor Urology Update, post graduate seminar (CME) Houston, TX
12/91 Faculty Update on the management of bladder disease (CME) New York, NY
12/91 Guest speaker Transrectal ultrasound in urology, Maimonides Hospital (CME) New York, NY
5/92 Faculty Problems with prosthetic devices, AUA instructional course #69, (CME) Washington, DC
12/92 Faculty Urologic prostheses (CME) New York, NY
12/92 Guest speaker Surgical treatment of impotence. Maimonides Hospital (CME) New York, NY
2/93 Faculty Ultrasound imaging of Peyronie's, NIH conference on Peyronie's disease Washington, DC
3/93 Faculty Treatment of male incontinence, AUA, NY-section post graduate seminar (CME) New York, NY
6/93 Director Update in the diagnosis & treatment of impotence, post graduate seminar (CME) New York, NY
1/94 Faculty Office evaluation of impotence, Non-injection medical therapy of impotence Penile prostheses. Surface coil MRI in staging of prostate cancer. Winter Urologic Forum post graduate seminar (CME) Steamboat, CO
1/94 Guest speaker Surgical management of impotence & double implants, (CME) Cabrini Hospital, New York, NY
2/94 Guest speaker Update in GU prostheses, Beth Israel Hospital, (CME) New York, NY
3/94 Faculty Diagnosis and treatment of impotence, (CME) Long Island College of pharmacy & Public Health, New York, NY
3/94 Faculty Diagnosis and treatment of impotence. Management of male infertility. Alternative therapies of BPH. Association of Clinical Pharmacologists, Annual Meeting, Session on Urology San Antonio, TX
6/94 Faculty Infection of genitourinary prosthesis 3rd Annual Urology Seminar, American Hospital of Paris, Paris, France
6/94 Faculty Medical treatment of impotence, AUA, NY Section Meeting (CME) Rye Brook, NY
11/94 Faculty Sexual dysfunction and Parkinson's disease, Meeting on Parkinson's disease, Columbia-Presbyterian medical Center, New York, NY
3/95 Visiting 1 week visiting professorship professor Kiev Institute of Urology & Nephrology The AUA International Cooperative Urologic Education Project
3/95 Guest speaker Innovations in the management of impotence, Lenox Hill Hospital, (CME) New York, NY
4/95 Guest speaker Update in the treatment of impotence, Winthrop Hospital, Long Island, (CME) Winthrop, NY
6/95 Faculty Intracavernous injections for the management of erectile dysfunction in patients with Peyronie's disease. Ultrasound in the diagnosis of Peyronie's disease. 6th International Meeting of Andrology. Universita Urbano Vaticano, Rome, Italy
11/95 Visiting Surgical workshop on impotence and Peyronie’s disease. Professor Achim, Germany
12/95 Director Diagnosis and treatment of erectile dysfunction, a guide to primary care Practitioners, (CME) New York, NY
3/96 Co-Director Erectile dysfunction, intracavernosal pharmacotherapy, (CME) Multidisciplinary perspective, international seminar, Universal City, CA
5/96 Speaker Medical update: Male potency problems, (CME) Annual Meeting of the American Psychiatric Association, New York, NY
7/96 Visiting Hospitals of the Adighe Autonomous Republic Professor Maikop, Russia
8/96 Faculty 11th International Course in Urology Quito, Ecuador
10/96 Faculty Do pills & creams cure impotence?, AUA, NY-section annual meeting, (CME) Paris, France
10/96 Faculty Update on penile prosthesis, AUA, NY-section annual meeting, (CME) Paris, France
11/96 Director Diagnosis and treatment of erectile dysfunction, an update, (CME) New York, NY
3/97 Speaker Non surgical therapy of erectile dysfunction Post graduate seminar, NY Academy of Medicine, NY Section AUA, (CME) New York, NY
6/97 Director Update on sexual dysfunction, satellite seminar, (CME) New York, NY
8/97 Speaker Erectile dysfunction, a seminar for primary care physicians, (CME) Anaheim, CA
9/97 Co-director Male sexual dysfunction, 2nd international seminar, (CME) Universal City, CA
9/97 Co-director Building a therapeutic alliance, an interactive seminar, (CME) Universal City, CA
10/97 Faculty Asia/Pacific Society for Impotence Research, biennial meeting Kuala Lumpur, Malaysia
10/97 Faculty AFUD & NIH Science writer conference. National Institutes of Health, Bethesda, MD
12/97 Faculty Consensus Panel on the Diagnosis & Treatment of Erectile Dysfunction, (CME) New York, NY
2/98 Faculty Diagnosis and Treatment of Erectile Dysfunction Royal College of Physicians London, United Kingdom
3/98 Guest speaker El Colegio Mexicano de Urologia, annual meeting, Monterrey, Mexico
8/98 Faculty Biennial meeting of the International Society of Impotence Research, (CME) Amsterdam, The Netherlands
9/98 Guest speaker Annual meeting of the Italian Society of Andrology Perugia, Italy
9/98 Guest faculty Innovations in urologic practice, Baylor College of Medicine, (CME) Santa Fe, NM
10/98 Co-director Male sexual dysfunction, 3rd international seminar, (CME) Universal City, CA
10/98 Faculty AFUD & NIH Science writer conference. National Institutes of Health, Bethesda, MD
10/98 Faculty AFUD Consensus Panel on Female Sexual Dysfunction, Boston, MA
2/99 Guest faculty African Society of Impotence Research, Cairo, Egypt
5/99 Speaker Society for the Study of Impotence annual meeting, (CME) Dallas, TX
7/99 Committee Economical Aspects of ED. International Consultation on ED Chairman sponsored by the World Health Organization, Paris, France
10/99 Co-director Male sexual dysfunction, 4th international seminar, (CME) Beverley Hills, CA
2/2000 Guest Alprostadil alfadex injection therapy versus intraurethral suppository speaker a comparative study, European Society for Impotence Research, Barcelona, Spain
3/2000 Guest faculty 1st Mediterranean Congress on Sexual Dysfunction Cairo, Egypt
4/2000 Director Advances in the treatment in erectile dysfunction, (CME) Atlanta, GA
5/2000 Faculty AUA course: Diagnosis & management of erectile dysfunction, (CME)
6/2000 Director Sexual Dysfunction 2000, (CME) Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD, New York, NY
11/2000 Co-chairman Male sexual dysfunction, 5th international seminar, (CME) Beverley Hills, CA
2/2001 Guest faculty 14th Annual Conference of the Saudi Urological Society Dammam, Saudi Arabia
5/2001 Director Sexual Dysfunction 2001, (CME) Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD, New York, NY
6/2001 Director Challenges & solutions in ED, (CME) Anaheim, CA
6/2001 Director AUA course: Update on ED, (CME)
10/2001 Faculty European Society for Sexual & Impotence Research (ESSIR) biennial meeting Rome, Italy
11/2001 Co-chairman Male sexual dysfunction, 6th international seminar, (CME) Beverley Hills, CA
3/2002 Faculty American College of Cardiology, Erectile Dysfunction symposium, (CME) Atlanta, GA
2/2002 Faculty AUA NY Section Special AUA 100th anniversary meeting New York, NY
5/2002 Director Challenges & solutions in ED, (CME) Orlando, FL
6/2002 Director Sexual Dysfunction 2002, (CME) Multidisciplinary update on ED, premature ejaculation, Peyronie’s & FSD, New York, NY
7/2002 Faculty 3rd International Conference on the Management of ED, (CME) McLean, VA
10/2002 Visiting Department of Urology, Pennsylvania State University Professor Hershey, PA
10/2002 Faculty AUA NY Section Annual meeting, (CME) Madrid, Spain
11/2002 Co-chairman Male sexual dysfunction, 7th international seminar, (CME) Beverley Hills, CA
11/2002 Faculty Update on ED seminar, Jefferson Medical College, (CME) Philadelphia, PA
12/2002 Guest faculty European Society for Sexual and Impotence Research Hamburg, Germany
12/2002 Faculty Science Writers Conference, American Foundation of Urologic Disease New York Academy of Medicine, New York, NY
2001-2002 Director Uro Blue Stage, Columbia University international urology seminar hosted six 3-day seminars with a total of 180 urologists from Italy Closed circuit transmission from OR and interactive lectures, New York, NY
2/2003 Chairman Chief resident debate, AUA NY Section / NY Academy of Medicine, New York, NY
6/2004 Director Sexual Dysfunction 2004, (CME) Multidisciplinary update on ED, premature ejaculation, Peyronie’s disease Priapism & hypogonadism, New York, NY
4/2005 Director Female Sexual Dysfunction 2005, (CME) Multidisciplinary update on female sexual dysfunction, New York, NY
6/2005 Director Male Sexual Dysfunction & Men’s Health, (CME) Multidisciplinary update on ED, premature ejaculation, Peyronie’s disease Priapism & hypogonadism New York, NY
9/2005 Faculty Standards committee of the International Society of Sexual Medicine (ISSM) Rudesheim, Germany
11/2005 Meeting Annual Fall Meeting Arrangement Sexual Medicine Society of North America, Chairman New York, NY
2/2006 Faculty 5th Annual Meeting, International Society for Study of the Aging Male (ISSAM) Salzburg, Austria
2/2006 Faculty 18th Annual Conference of the Saudi Urological Society Jeddah, Saudi Arabia

Member, editorial board

Journal of Sexual Medicine, official journal of the International Society of Sexual Medicine, Blackwell Publishing
World Journal of Urology, Springer Verlag
The Aging Male, Parthenon Publishing
Sexual Dysfunction in Medicine, Remedica Publishing
Medical Aspects of Human Sexuality, Quadrant HealthCom, Inc
American Journal of Urology Review
The Journal of Men’s Health and Gender

Member, editorial review board

Journal of Urology, Lippincott Williams & Wilkins
Urology, Elsevier
BJU International, Blackwell
European Urology, Elsevier
Journal of Sexual Medicine, Blackwell
International Journal of Impotence Research, Nature Publishing

Bibliography:

A. Original papers, (peer review):

F.B. Scott, I.J. Fishman, & R. Shabsigh: The impact of the artificial urinary sphincter on the upper urinary tracts in the neurogenic bladder. J. Urol., 136:636, 1986.
I.J. Fishman, R. Shabsigh & A.L. Kaplan: Lower urinary tract dysfunction after radical hysterectomy for carcinoma of the cervix. Urol., 28:462, 1986.
R. Shabsigh*, I.J. Fishman & M. Krebs: The use of transrectal longitudinal real-time ultrasonography in urodynamics. J. Urol., 138:1416, 1987.
R. Shabsigh*, I.J. Fishman & M. Krebs: Combined transrectal ultrasonography and urodynamics in the evaluation of detrusor sphincter dyssynergia. Br. J. Urol., 62: 326, 1988.
R. M. Decter, D.R. Roth, I.J. Fishman, R. Shabsigh, F.B. Scott & E.T. Gonzales: The use of AS-800 in extrophy-epispadias. J. Urol., 140: 1202, 1988.
R. Shabsigh*, I.J. Fishman & F.B. Scott: Evaluation of erectile impotence. Urol., 32: 83, 1988.
M.J. Gleeson, R. Shabsigh & D.P. Griffith: Outcome of ESWL in patients with multiple renal calculi based on stone burden and location. J. Endourol., 2: 145, 1988.
I.J. Fishman, R. Shabsigh & F.B. Scott: Experience with the artificial urinary sphincter AS-800 in 148 patients. J. Urol., 141: 307, 1989.
M.J. Gleeson, R. Shabsigh & D.P. Griffith: ESWL monotherapy of renal calculi substratified by site, size and multiplicity. Scan. J. Nephrol. & Urol., supplementum 122: 11, 1989.
R. Shabsigh*, S. Lerner, I.J. Fishman & D. Kadmon: The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. J. Urol., 141: 1206, 1989
R. Shabsigh*, D. Kadmon, I.J. Fishman: Ultrasonographically guided transperineal prostate biopsy in patients with suspicious glands and previously negative digitally guided biopsies. J. Endourol., 3: 185, 1989.
R. Shabsigh*, I.J. Fishman, E.T. Quesada & C. Seale-Hawkins: Evaluation of vasculogenic erectile impotence using duplex ultrasonography. J. Urol., 142: 1469, 1989.
R. Shabsigh*, I.J. Fishman, Y. Shotland, I. Karacan & J.K. Dunn: Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J. Urol., 143: 924, 1990.
R. Shabsigh*, S. Lerner, I.J. Fishman & D. Kadmon: The role of transrectal ultrasonography in the diagnosis and management of prostatic and seminal vesicle cysts. Abstracts International, 1990.
R. Shabsigh*, I.J. Fishman & C. Schum: The role of cigarette smoking and other vascular risk factors in the pathogenesis of impotence. Urol., 38: 227, 1991.
R. Shabsigh*, I.J. Fishman, B.D. Toombs & M. Skolkin: Venous leaks: anatomic and physiologic observations. J. Urol., 146: 1234, 1991.
R. Shabsigh*: Sports-trauma-related impotence; treatment with penile revascularization. med. Asp. Hum. Sex., March: 56, 1991.
S.A. Kaplan, R. Shabsigh, K.A. Soldo & C.A. Olsson: Prostatic and periprostatic interstitial temperature measurements during transrectal thermal therapy (local intracavitary microwave hyperthermia). J. Urol., 147: 1562, 1992.
A.E. Te, M. Colombel, H.P. Koo, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Castration-induced apoptosis in the rat penis. Surg. Forum, 43: 724, 1992.
S. A. Kaplan, R. Shabsigh, K.A. Soldo, J.G. Blaivas & C.A. Olsson: Transrectal hyperthermia in the management of men with prostatism: an algorithm for therapy. Br. J. Urol., 72: 195-200, 1993.
R. Shabsigh*: medication-related impotence. Contemp. Urol., 5:51, 1993.
A.E. Te, R.P. Santarosa, H.P. Koo, S.A. Kaplan, C.A. Olsson, R. Buttyan & R. Shabsigh*: Neurotrophins in the diabetic rat penis, a long-term study. Surg. Forum, 44: 758, 1993.
H.P. Koo, R.P. Santarosa, R. Buttyan, R.Shabsigh, C.A. Olsson & S. Kaplan: Early molecular changes associated with streptozotocin induced diabetic bladder hypertrophy in the rat. Urol. Res. 21: 375-381, 1994.
A.E. Te, R.P. Santarosa, H.P. Koo, R. Buttyan, L. Greene, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophic factors in the rat penis. J. Urol., 152: 2167-2172, 1994.
A. J. Kirsch, D.T. Chang, M.I. Miller, J.P. Connor, T.W. Hensle and R. Shabsigh*: Laser-welding versus suturing in tunica vaginalis and venous patch graft corporoplasty. J. Urol. 154: 854-857, 1995.
A. J. Kirsch, M.I. Miller, T.W. Hensle D.T.Chang, R. Shabsigh*, C.A. Olsson, & , J.P. Connor: Laser-tissue soldering in urinary tract reconstruction: First human experience. Urol. 46: 261-6, 1995.
E. K. Seaman, I. S. Sawczuk, M. Fatal, C. A. Olsson & R. Shabsigh*: Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Urol., 47: 353-355, 1996.
H. Padma-Nathan, W.J.G. Hellstrom, F.E. Kaiser, R.F. Labasky, T.F. Lue, W.E. Nolten, P.C. Norwood, C.A. Peterson, R. Shabsigh, P.Y. Tam, V.A. Place, &N. Gesundheit: Treatment of erectile dysfunction in men by transurethral Alprostadil. N. Engl. J. Med., 336: 1-7, 1997.
L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Apoptosis in the rat penis after denervation. J. Urol., 158: 626-630, 1997.
R. Shabsigh*: The role of testosterone in the cavernous tissue and its neural supply. World J. Urol., 15: 21-26, 1997.
R. Shabsigh*, L. Klein, S. Seidman, S.A. Kaplan, Lerhoff, & J. Ritter: High incidence of depressive symptoms is associated with erectile dysfunction. Urol. 52: 848-852, 1998.
R.A. Constabile, M. Spivak, I.J. Fishman, F.E. Govier, W.J.G. Hellstrom, R. Shabsigh, K. Nemo, J. Rapport, P. Tam, K. Weldon, & N. Gesundheit: Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J. Urol., 160: 1325-8, 1998.
R. Shabsigh*, J. Raymond, Carl A. Olsson, K. O’Toole, & R. Buttyan: Androgen induction of DNA synthesis in the rat penis. Urol. 52: 723-8, 1998.
S.A. Kaplan, R.B. Reis, I.J. Kohn, R. Shabsigh, & A.E. Te: Combination therapy utilizing oral alpha blockers and intracavernosal injections in men with erectile dysfunction. Urol. 52: 739-743, 1998.
M. Burchard, T. Burchardt, M.-W. Chen, A. Shabsigh, A. de la Taille, R. Buttyan, & R. Shabsigh*: Expression of messenger RNA splice variants for VEGF in the adult rat and human penis. Biol. Repr., 60: 398-404, 1999.
T. Burchard, M. Burchardt, M.-W. Chen, R. Buttyan, A. de la Taille, A. Shabsigh, & R. Shabsigh*: Expression of VEGF splice variants 144/145 and 205/206 in the adult male tissue. IUBMB Life, 48: 405-8, 1999.
R. Shabsigh*: Efficacy of sildenafil citrate (VIAGRA) is not affected by aetiology of erectile dysfunction. Int J Clin Pract Suppl 102: 19-20, 1999.
R. Rosen, I. Goldstein, J. Heiman, S. Korenman, M. Lakin, T. Lue, D.K. Montague, H. Padma-Nathan, R. Sadovsky, R.T. Segraves, R. Shabsigh: The process of care model for evaluation and treatment of erectile dysfunction. IJIR, 11: 59-74, 1999.
SN Seidman, R. Shabsigh & SP Roose: Phamacologic treatments of sexual dysfunction. Psych Cl N Am: Annual of Drug Therapy, 6: 21-33, 1999.
A. Shabsigh, N. Tanji, V. D’Agati, T. Burchardt, M. Burchardt, O. Hayek, R. Shabsigh*, & R. Buttyan: Vascular anatomy of the rat ventral prostate. The Anat Rec, 256: 403-411, 1999.
A. Shabsigh, R. Buttyan, T. Burchardt, O. Hayek, V. D’Agati, C. Olsson, & R. Shabsigh*: The Microvascular Architecture of the Rat Vagina Revealed by Image Analysis of Vascular Corrosion Casts. IJIR, 11: S23-S30, 1999.
R. Shabsigh*, A. Shabsigh, M. Burchardt, T. Burchardt, & J. Karden: Erectile dysfunction and depression: a dynamic association. Sex Dysf. 2: 32-33, 1999.
R. Shabsigh*, H. Padma-Nathan, M. Gittleman, J. McMurray. J. Kaufman J & I. Goldstein: Intracavernous alprostadil (EDEX/VIRIDAL) is more efficacious, better tolerated and more preferred than intraurethral alprostadil (MUSE plus ACTIS ): a comparative, randomized, cross-over, multi-center study. Urol., 55: 109-113, 2000.
R Basson, J Berman, A Burnett, L Derogatis, D Ferguson, J Fourcroy, I Goldstein, A Graziottin, J Heiman, E Laan, S Leiblum, H Padma-Nathan, R Rosen, K Segraves,RT Segraves, R Shabsigh, M Sipski, G Wagner G, B Whipple, et al: Report on the international consensus development conference on female sexual dysfunction: definitions & classifications. J. Urol., 163: 888-893, 2000.
R. Shabsigh*: Erectile dysfunction and depressive symptoms: an intricate association. Contem. Urol., CME suppl, 16-20, 2000.
M. Burchardt, T. Burchardt, j. Kardan, P. Ying Ng, A. Shabsigh, A. de La Taille, O. Hayek, R. Buttyan, & R. Shabsigh*: Diabetes is associated with reduced cavernosal endothelial cells and smooth muscles: study in aged, and diabetic rats. J. Urol., 2000 Nov. 164: 1807-1811.
R. Shabsigh*, H. Padma-Nathan, M. Gittleman, J. McMurray. J. Kaufman J5 & I. Goldstein: Intracavernous alprostadil (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urol., 55: 477-480, 2000.
M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh*: Hypertension is associated with severe erectile dysfunction. J. Urol., 164: 1188-1191, 2000.
R. Rosen, C. Brown, J. Heiman, S. Leiblum, C. Meston, R. Shabsigh,, D. Ferguson, R. D'Agostino, Jr.: The index of female sexual function (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J. Sex & Mar. Ther., 2000, 26: 191-208.
R. Shabsigh*: Recent developments in male sexual dysfunction. Cur Psych Rep., 2: 196-200, 2000.
R. Shabsigh*: New advances in the management of Peyronie’s disease. Mediguide to Urology, 2000, 13: 1-5.
E. Fagelman, A. Fagelman & R. Shabsigh*: Efficacy, safety and use of sildendafil in urologic practice. Urol., 57:1141-1144, 2001.
R. Shabsigh*: Prevalence and recent developments in female sexual dysfunction:. Cur Psych Rep., 3:188-194, 2001.
S. Seidman, R. Rosen, M. Menza, S. Roose, & R. Shabsigh: Treatment of erectile dysfunction improves symptoms of depression in men with comorbid depression: results of a placebo controlled clinical trial of sildenafil citrate. AJP, 158: 1623-1630, 2001.
A. Anastasiades, SK. Wilson, & R. Shabsigh*: Long term outcomes of inflatable penile implants: reliability, patient satisfaction and complication management. Curr Op Urol., 11: 619-623, 2001.
M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh*: Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. IJIR, 2001, 13:276-281.
R. Shabsigh*, L. Zakaria, A. Anastasiadis & S. Seidman: Sexual dysfunction and depression: Etiology, Prevalence and Treatment. Curr Urol Rep., 2001, 2:463-467.
Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh, R, & Steers W.: Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res. 2001 Dec; 13 Suppl 5:S39-43.
L. Zakaria, A. Anastasiades, & R. Shabsigh*: Common conditions in the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int. Urol & Nephrol, 33: 283-292, 2001.
M. Burchardt, T. Burchardt, L. Baer, A.J. Kiss, R.V. Pawar, A. Shabsigh, A. DeTaille, O.R. Hayek, & R. Shabsigh*: Sexual dysfunction is common and overlooked in female patients with hypertension. J. Sex & Mar. Ther., 28: 17-26, 2002.
R, Shabsigh*, A. Anastasiades, MA, Ghafar, and M, Burchardt: Economic aspects of medical erectile dysfunction therapies. Expert Opin Pharmacother, 3 (3), 257-263, 2002.
A. Anastasiades, F. Facherot, MA Ghafar, P. Benedit, M-W. Chen, A. Shabsigh, M. Burchardt, D. Chopin, R. Shabsigh, & R. Buttyan: Hormone refractory human prostate Ca can harbor mutations in the O2 dependant degradation domain of hypoxia inducible factor – alpha 1. J. Cancer Res Cl Onc, 128: 358-362, 2002.
A. Anastasiades, AR Davis, MA, Ghafar, M, Burchardt, & R, Shabsigh*: Epidemiology and definition of female sexual disorders. World J Urol, 20:74-78, 2002.
AR Davis, R Shabsigh*, S Nowygrod, & C Westhoff: The influence of vaginal bleeding on the sexual behavior of urban Hispanic women and Men. Contraception, 65(5): 351-355, 2002.
HG. Nurnberg, SN. Seidman, AJ. Gelenberg, M. Fava, R. Rosen & R. Shabsigh: Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression. Urol., 60 suppl. B: 58-66, 2002.
A G. Anastasiades, A R Davis, & R. Shabsigh*: Hormonal factors in female sexual dysfunctions. Curr Op Urol., 12: 505-507,2002.
A. G. Anastasiades, L. Salamon, M. Ghafar, M. Burchardt, & R. Shabsigh*: Female sexual dysfunction, state of the art. Curr Urol Rep, 3 (6): 484-491, 2002.
R. Shabsigh* & A. Anastasiades,: Erectile dysfunction. Annual Reviews in Medicine., 2003, 54: 153-168.
S. Stass, A. Anastasiades, H. Fisch, MC Benson, & R. Shabsigh*: Urologic aspects of andropause. Urol, 61 (2): 261-266, 2003.
A. Anastasiades, MC Benson, MP Rosenwasser, H. El-Rashidy, MA Ghafar, JM McKiernan, M. Burchardt & R. Shabsigh*: Cavernous nerve graft reconstruction during radical prostatectomy and radical cystectomy: safe and technically feasible. Prostate Cancer PD, 6: 56-60, 2003.
Nehra A, Steers WD, Althof SE, Andersson KE, Burnett AL 2nd, Costabile RA, Goldstein I, Kloner RA, Lue TF, Morales A, Rosen RC, Shabsigh R, Siroky MB, King L.: Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003 Aug;170(2):S3-S5.
R. Shabsigh*:Hypogonadism and erectile dysfunction: the role of testosterone therapy. Int J Impot Res. 2003 Aug;15 Suppl 4:S9-13.
A. G Anastasiadis, R. Sachdev, L. Salomon, MA. Ghafar, BC Stisser, R. Shabsigh, & AE Katz: Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003 Dec;129(12):676-82.
A. Anastasiades, A.R. Davis, I.S. Sawczuk, M. Fleming, M.A. Perelman, & R. Shabsigh*: Sexual functioning in kidney cancer patients, data from a national registry. Support Care Cancer. 2003 Nov;11(11):700-6.
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G.Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004 Jul;1(1):6-23.
R. Rosen, SN, Seidman, M. Menza, R. Shabsigh, S. Roose, A. Tseng, D. Orazem, and R. Siegel: QoL, Mood, and Sexual Function: A Path Analytic Model of Treatment Effects in Men With ED and Depressive Symptoms. IJIR, 16: 2004.
R. Shabsigh*: Therapy of ED: PDE5 inhibitors. Endocrine. 23(2-3):135-42, 2004 Mar.
R. Shabsigh*, JM Kaufman, C. Steidle, H. Padma-Nathan: Randomized study of AndroGel® (testosterone gel) as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J. Urol., 172: 658-663, 2004.
JA Taylor, TC Kao, PC Albertson & R. Shabsigh*: Bicycle riding and its relationship to the development of erectile dysfunction. J. Urol., 172: 1028-1031, 2004.
R. Shabsigh*, M. Perelman, EO Laumann, & D. Lockhardt: Drivers and barriers to seeking treatment for erectile dysfunction, a comparison of 6 countries. BJU Int. 94(7):1055-65, 2004.
R. Shabsigh*: Testosterone therapy in erectile dysfunction. The Aging Male 2004;7:312–318.
RC Rosen, H Padma-Nathan, R Shabsigh, JS Whitaker, K Saikali, V Watkins, W Pullman, G Anglin, T Costigan & WH Cordell: A multi-center, randomized, double-blind, placebo-controlled, at-home study to determine the earliest time within 30 minutes to erectogenic effect after tadalafil 10mg and 20mg. J Sex Med, 1: 193-200, 2004.
T. Ebert, F. Jockenhovel, A. Morales, R. Shabsigh*. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. Eur Urol. 2005 Feb;47(2):137-46.
CC Carson, R. Shabsigh, S. Segal, A. Murphy, & P. Fredlund: Efficacy, safety and treatment satisfaction of Tadalafil versus placebo in men with erectile dysfunction, evaluated at tertiary care academic centers. Urology. 2005 Feb;65(2):353-9.
C. Smith, C. McMahon & R. Shabsigh*: Peyronie’s disease, epidemiology, pathophysiology and diagnostic evaluation. BJU Int., 95: 729-732, 2005.
M. Perelman, R. Shabsigh*, AD Seftel, S. Althoff & D Lockhardt: Attitudes of men with erectile dysfunction, a cross national survey. J. Sex Med., 2: 397-406, 2005.
D. Droggin, AG. Anastasiadis, & R. Shabsigh*: Antibiotic coating reduces penile prosthesis infection. J Sex Med, 2: 565-568, 2005.
R. Rosen, G. Broderick, R. Shabsigh, R. Swindle, D. Lockhardt, & A. Cameron: Sensitivity of the Psychological and Interpersonal Relationship Scales to (PAIRS) Oral Therapies. J Sex Med 2: 461-468, 2005.
R. Shabsigh*, M. Perelman, TF Lue, GA Broderick, & D. Lockhardt: Men’s health issues: prevalence and correlates of erectile dysfunction. J Urol, 174: 662-667, 2005.
JB. Kostis, G Jackson, R Rosen, E Barrett-Connor, K Billups, A Burnett, C Carson, M Cheitlin, R DeBusk, V Fonseca, P Ganz, I Goldstein, A Guay, D Hatzichristou, JE. Hollander, Ad Hutter, St Katz, R Kloner, M Mittleman, F Montorsi, P Montorsi, A Nehra, R Sadovsky, R Shabsigh: Sexual dysfunction and cardiac risk, the 2nd Princeton consensus conference. Am J Cardiol. 15;96(2):313-21 2005 AJC, 2005.
N. Makhsida, J. Shah, G. Yan, H. Fisch & R. Shabsigh*: Hypogonadism and the metabolic syndrome, implications for testosterone therapy. J. Urol., 174:827-834, 2005.
A. Shabsigh, Y Kang, R. Shabsigh , M Gonzalez, G Liberson, H. Fisch, & E. Goluboff: Clomiphene Citrate Effects on Testosterone/Estrogen Ratio in Male Hypogonadism. J Sex Med, 2: 716-722, 2005.
M. Burchardt, T. Burchardt, AG Anastasiadis, R. Buttyan, A. de La Taille, A. Shabsigh, J. Frank, & R. Shabsigh*: Application of Angiogenic Factors for Therapy of Erectile Dysfunction: Protein and DNA Transfer of VEGF165 into the Rat Penis. Urol. 66 (3), 665-670, 2005.
R Shabsigh*, AL Burnett, I Eardley, ID Sharlip, PI Ellsworth, CS Garcia, F Natanegara, & S Ahuja : Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. BJU Int, 96, 857-863, 2005.
R. Shabsigh*: Testosterone therapy in erectile dysfunction and hypogonadism. J Sex Med 2005; 2: 785-792.
RC Rosen, R Shabsigh, L Kuritzky, WC Wang, GD Sides: The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Curr Med Res Opin. 2005 Nov; 21(11):1701-9.
R Rosen, R Shabsigh, M Berber, P Assalian, M Menza, L Rodriguez-Vela, R Porto, K Bangerter, M Seger, F Montorsi.: Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry. 2006 Jan;163(1):79-87.
R Shabsigh*, M Katz, G Yan, N Makhsida: Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol. 2005 Dec 26;96(12 Suppl 2):67-72. Epub 2005 Dec 19.
Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C 3rd, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R. Sexual dysfunction and cardiac Risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005 Dec 26;96(12B):85M-93M. Epub 2005 Dec 27.
A Yassin, F Saad, CE Hoesl, AM Traish, M Hammadeh & R Shabsigh: Alpha adrenoreceptors are a common denominator in the pathophysiology of erectile dysfunction and BPH/LUTS – implications for clinical practice. Andrologia. 2006 Feb;38(1):1-12.
HG. Nurnberg, AJ. Gelenberg, M. Fava, R. Shabsigh, SN. Seidman, R. Rosen: Treatment of Serotonergic Reuptake Inhibitor-Induced Erectile Dysfunction: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Urol, 2006, in press.
R. Shabsigh*: Urological Perspectives on Andropause. Psych Ann, 2006, accepted, in press.
R Munarriz, R Mittal, KL Billups, FD Borges, SE Dakil, JR Delk, CB Dhabuwala, WP Fitch, MG Fry, LS Hakim, H Hanafy, WT Hitt, JM Kaufman, DT McKnight, JR Ross, BN Secrest, R Shabsigh, D Collins, PE Wherry, SK Wilson, C Wen, P Salimpour, K Min & I Goldstein: The Mentor Alpha-1 penile prosthesis with lock-out valve: a solution to autoinflation. Androl, 2006, accepted, in press.
C. McMahon, C. Smith & R. Shabsigh*: Treatment of erectile dysfunction after PDE-5 inhibitor failure. BMJ accepted, in press, 2006.
TW Hensle, A Shabsigh, R Shabsigh, EA Reily, & H Mayer-Bahlburg: Sexual function following bowel vaginoplasty. J Urol, accepted, in press, 2006.
JL. Pryor, J Barada, S Althof, C Steidle, R Rosen, W Hellstrom, R Shabsigh, S Kell, & M Miloslavsky, for the Dapoxetine Study Group: Efficacy and Tolerability of Dapoxetine in the Treatment of Premature Ejaculation: Integrated Analysis of Two Randomized, Double-blind, Placebo-controlled Trials. JAMA 2005, submitted.
R. Shabsigh* & B Stone: Understanding ED patient needs and objectives. JSM., 2006 sumbitted.
H. Padma-Nathan, R. Shabsigh, R. Weiss, DD. Michie, & R. Rosen: Efficacy and safety of alprostadil (Caverject) in sildenafil (Viagra) failures. IJIR, 2006, submitted.
JC. Trussel, AG. Anastasiadis, & R. Shabsigh*: Straitening out Peyronie’s disease. Europ Urol, 2006 submitted.
CC Carson, R. Shabsigh, S. Segal, A. Murphy, & P. Fredlund: Tadalafil for erectile dysfunction: efficacy, safety and treatment satisfaction. Mayo Cl Proceedings 2006, submitted.
A. Anastasiadis, I. Goldstein, L. Lipshultz, H. Padma-Nathan, R. Shabsigh*, & P. Lammers: The treatment of male erectile dysfunction with injectable combination of papaverine, phentolamine and prostaglandin E1. J Sex Med, 2006, submitted.
R. Shabsigh*, & A. Davis: Female sexual dysfunction in partners of men with ED. Urol., 2006, submitted.
V Kupelian, R Shabsigh, AB. Araujo, AB O’Donnell, JB McKinlay: Erectild dysfunction as a predictor for the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study (MMAS). J Urol, 2006, submitted.
T. Travison, R Shabsigh, V Kupelian, AB. Araujo, AB O’Donnell, JB McKinlay: Natural progression and remission of erectild dysfunction: results from the Massachusetts Male Aging Study (MMAS). JAMA, 2006, submitted.

B. Case reports:

1. I.J. Fishman, R. Shabsigh & F.B. Scott: Urinary undiversion and implantation of the artificial urinary sphincter in a 73 year old male. J. Urol., 138:140-2, 1987.
2. M. Rosen & R. Shabsigh*: Post TURP ejaculatory duct obstruction. J. Urol., 149: 1555-6, 1993.
3. R.P. Santarosa, T. Hensle & R. Shabsigh*: Percutaneous transvesical ureteroscopy for the removal of a distal ureteral stone in a reimplanted ureter. Urol: 42: 227-9, 1993.
4. E. Seaman, M.C. Benson & R. Shabsigh*: Percutaneous management of an Indiana pouch calculus. J. Urol., 151: 690-692, 1994.

C. Reviews, chapters & editorials:

1. R. Shabsigh*, M.J. Gleeson & D.P. Griffith: The benefits of stenting on a more or less routine basis. Urol. Cl. N.Am., 15:493-497, 1988.
M.J. Gleeson, R. Shabsigh & D.P. Griffith: Outcome of ESWL in patients with multiple renal calculi based on stone burden and location. Shock Wave Lithotripsy: State of the Art, 1989.
I.J. Fishman & R. Shabsigh: The artificial urinary sphincter AS-800 in the adult. Current Operative Urology, Edited by: E.D. Whitehead. Lippincott, Philadelphia, 1990, Part 3, pp. 116-128.
D.R. Greene, R. Shabsigh & P.T. Scardino: Urologic Ultrasonography. Campbell's Urology, Edited by P.C. Walsh, A.B. Retik, T.A. Stamey & E.D. Vaughn. W.B. Saunders Co., 1992, Vol 1, pp. 342-393.
R. Shabsigh* & J.G. Blaivas: Urinary and sexual dysfunction. In: Cancer of the colon, rectum and anus, Edited by: A.M. Cohen, S.J. Winawer, M.A. Friedman & L.L. Gunderson, McGraw-Hill Inc., New York, 1994, pp 787-795.
R. Shabsigh* & J.G. Blaivas: The bladder after abdomino-perineal excision of the rectum. Clinical Urology. Edited by: Hugh Whitfield, Bill Hendry, R. S. Kirby & John Duckett. Blackwell Scientific Publishers, London, 1995.
I.S. Sawczuk, R. Shabsigh, H. Nagler & C.A. Olsson: The Genitourinary system. Columbia-Presbyterian Medical Book, 1994.
R. Shabsigh*: Editorial: Impotence on the rise as a urologic subspecialty. J. Urol., 155: 924-925, 1996.
R. Shabsigh*: Editorial: Penile prosthesis at the end of the millenium. J. Urol., 159: 819, 1998.
H. Padma-Nathan, & R. Shabsigh: Sildenafil Citrate (Viagra): a Review. American Urological Association Update Series, Vol 58, lesson 35: 274-280, 1999.
R. Shabsigh*: Economical Aspects of erectile dysfunction. Ch 2 in: Erectile Dysfunction, 1st International Consultation on ED co-sponsored by the World Health Organization (WHO), International Society of Impotence Research (ISIR) and Societe Internationale d’Urologie (SIU), Edited by A. Jardin, G. Wagner, S. Khouri, & F. Giuliano,H. Padma-Nathan, & R. Rosen, Health Publications Ltd 2000.
R. Shabsigh: Strategic planning in research and development is needed in female sexual dysfunction. J. Sex & Mar. Ther., 27: 209-210, 2001.
R. Shabsigh*: Socioeconomic considerations in erectile dysfunction treatment. Urol. Cl. N.Am., 28: 417-422, 2001.
R. Shabsigh*: Editor-in-chief: Sildenafil Viagra Three Years Later, A worldwide review of clinical articles from the scientific literature, a CME book sponsored by Columbia University Center for Continuing Medical Education. PharmaLibri Publishers Inc, Montreal, Canada, 2001.
R. Shabsigh*: Intra-Corporal Therapy. Male Sexual Function: a Guide to Clinical Management, Edited by J.J. Mulcahy, Humana Press Inc, 2001, Totowa, New Jersey, Ch. 13, pp 245-251.
R. Shabsigh*: Female sexual dysfunction. New chapter in Campbell’s Urology, edited by PC Walsh, Saunders, Philadelphia, Pennsylvania, 2002, Ch 48, pp 1710-1733.
R. Shabsigh*: Back to Great Sex, Overcome ED and Reclaim Lost Intimacy. Kensington Books, New York, 2002. (patient education book, 226 pages).
R. Shabsigh*: Sexual dysfunction and reproductive sciences, advances on several fronts in the new millennium: editorial review. Curr Op Urol., 12: 491-492, 2002.
Shabsigh R.: Is there enough evidence for the pharmacological treatment of female sexual dysfunction, with vasoactive drugs? J Sex med. 2004 Nov; 1(s1):23.
AG. Anastasiadis, D. Droggin, AR. Davis, L. Salomon & R. Shabsigh: Male and female sexual dysfunction: epidemiology, pathophysiology, classification and treatment. Chapter In: Principles of Gender Specific Medicine, edited by: Marianne J. Legato, Elsevier Science, San Diego, California, 2004, chapt 52, pp 573-585.
AG. Anastasiadis, D. Droggin, M. Burchardt, & R. Shabsigh: Physiology of erection and causes of erectile dysfunction. Chapter in: Heart disease and erectile dysfunction, edited by: Robert A. Kloner, Humana Press, Totowa, New Jersey, 2004.
AG. Anastasiadis, DL Bemis, JC Trussell, BC Stisser & R. Shabsigh: Gene therapy for erectile dysfunction. Chapter in: Male and Female Sexual Dysfunction, edited by Allen D. Seftel, Mosby Elsevier Science, London, UK, 2004, chapter 12, pp183-190.
R. Shabsigh* et al: Economical Aspects of Sexual Dysfunction. Ch 4 in: Sexual Medicine: Sexual Dysfunction in Men and Women, 2nd International Consultation on Sexual and Erectile Dysfunction co-sponsored by the World Health Organization (WHO), International Society of Sexual and Impotence Research (ISIR) and Societe Internationale d’Urologie (SIU), Edited by TF Lue, R. Rosen, F. Giuliano, S. Khouri, & F. Montorsi, Health Publications Ltd, Paris, 2004.
R Shabsigh*, AR Davis, AG Anastasiadis, N Makhsida & G Yan: Female sexual dysfunction, Is there a magic pill?. Chapter in: Oral Pharmacotherapy for male Sexual Dysfunction, A Guide to Clinical Management, edited by Gregory A. Broderick, Humana Press, Totowa, New Jersey, 2005.
Althof SE, Goldstein I, Becher E, Giraldi A, Vardi Y, Dennerstein L, Marson L, Brotto L, Schreiner-Engel P, Wallen K, Clayton A, Altman A, Kingsberg S, Shabsigh R.: The other side: failure in fair and balanced reporting. J Sex Med. 2005 Jul;2(4):583-4.
P Masson, SM Lambert, M Brown & R Shabsigh: PDE-5 inhibitors current status and future trends. Urol Cl in North Am, 32(4): 511-525, 2005.

D. Abstracts:

1. I.J. Fishman, R. Shabsigh: Effects of botulinum toxin on the detrusor muscle of the rabbit for possible treatment neurogenic detrusor hyperreflexia. Canadian Urological Association Annual Meeting, Montreal, Canada, 1985.
R. Shabsigh*, I.J. Fishman & F.B. Scott: Clinical experience with the artificial urinary sphincter AS-792/1 & AS-800 in 546 patients. German Urological Congress Annual Mtg., Cuxhaven, Germany, 1985.
R. Shabsigh*, I.J. Fishman & F.B. Scott: Clinical experience with the inflatable penile prosthesis IPP-700 in 191 patients. German Urological Congress Annual Meeting, Cuxhaven, Germany, 1985.
I.J. Fishman, R. Shabsigh & A.L. Kaplan: Lower urinary tract dysfunction after radical hysterectomy for carcinoma of the cervix. J. Urol., 133: 306A, Abstract A#770, 1985.
R. Shabsigh*, I.J. Fishman & M. Krebs: The use of transrectal longitudinal real-time ultrasonography in urodynamics. J. Urol., 135: 157A, Abstract #216, 1986.
R. Shabsigh*, I.J. Fishman & F.B. Scott: Diagnosis of erectile impotence. German Urological Congress Annual Mtg., Bremerhaven, Germany, 1986.
R. Shabsigh*, I.J. Fishman & F.B. Scott: Therapy of erectile impotence. German Urological Congress Annual Mtg., Bremerhaven, Germany, 1986.
I.J. Fishman, R. Shabsigh & F.B. Scott: Experience with the artificial urinary sphincter AS-800 in 148 patients. J. Urol., 137: 232A, Abstract #514, 1987.
R.M. Decter, D.R. Roth, I.J. Fishman, R.Shabsigh, F.B. Scott & E.T. Gonzales: the use of AS-800 in extrophy-epispadias. J. Urol., 139, 1988.
R. Shabsigh*, I.J. Fishman, E.T. Quesada & C. Seale-Hawkins: Evaluation of vasculogenic erectile impotence using duplex ultrasonography. J. Urol., 139, 1989.
R. Shabsigh*, S. St.C. Carter, S. Egawa, J.D. Wright, C.E. Carlton, Jr., & P.T. Scardino: Transrectal ultrasound and/or digitally guided biopsy of the prostate. J. Urol., 141: 282A, Abstract #449, 1989.
R. Shabsigh*, M.J. Gleeson & I.J. Fishman: Penile vascular evaluation in diabetic and non-diabetic patients presenting with impotence; a comparative study. Texas Urological Society Annual Mtg., El Paso, TX, 1989.
R. Shabsigh*, I.J. Fishman, B.D. Toombs & M. Skolkin: Venous leaks: anatomic and physiologic observations. J. Urol., 143: 302A, Abstract A#456, 1990.
H.M. Landa, R. Shabsigh, D.R. Roth & E.T. Gonzales: Continent diversion in children. J. Urol., 143: 400A, Abstract #845, 1990.
E.T. Quesada, R. Shabsigh, I.J. Fishman & F.B. Scott: Management of Peyronie's disease with the inflatable penile prosthesis: 190 cases. J. Urol., 145: 238A, Abstract #102, 1991.
H.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Molecular changes in the penis of diabetic rats. AUA, NY-section Annual Mtg., Scottsdale, AZ, 1991.
H.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh: Molecular response in the bladder to the induction of diabetes in the rat. AUA, NY-section Annual mtg., Scottsdale, AZ, 1991.
R. Shabsigh*, A.E. Te, H.P. Koo, S.A. Kaplan, C.A. Olsson & R. Buttyan: Localization of nerve growth factor beta (NGF) in the rat penis by in-situ hybridization. Society for Basic Urologic Research, Fall Symposium, Rochester, MN, 1991.
S. A. Kaplan, R. Shabsigh & J.G. Blaivas: The use of prostatic stents in the management of prostatism in geriatric men. Urodynamic Society Annual Mtg., 1992.
A.E. Te, M. Colombel, H.P. Koo, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Castration-induced apoptosis in the rat penis. ACS Annual Mtg., Chicago, IL, 1992.
S. A. Kaplan & R. Shabsigh: Endoscopic and ultrasound visualization of insertion of a prostatic stent. J. Urol., 147: 208A, Abstract #V-84, 1992.
A.E. Te, R. Buttyan, L. Greene, S.A. Kaplan, H.P. Koo, R. Buttyan, C.A. Olsson & R. Shabsigh*: Abundant expression of nerve growth factor (NGF) in the rat penis, a developmental study. J. Urol., 147: 239A, Abstract #102, 1992.
H.P. Koo, A.E. Te, R. Buttyan, L. Greene, S.A. Kaplan, R. Buttyan, C.A. Olsson & R. Shabsigh*: Neurotrophin expression in diabetic rat penis: a new insight into the pathogenesis of diabetic erectile dysfunction. J. Urol., 147: 240A, Abstract #108, 1992.
R. Shabsigh, H.P. Koo, A.E. Te, S.A. Kaplan, R. Buttyan, C.A. Olsson: Expression of neurotrophins*: NGF, BDNF and CNTF in the rat penis. J. Urol., 147: 318A, Abstract #422, 1992.
A.E. Te., R. Buttyan, H.P. Koo, R. Shabsigh, C.A. Olsson & S.A. Kaplan: Nerve growth factor in diabetic cystopathy. J. Urol., 147: 350A, Abstract #550, 1992.
R. Shabsigh*, A. E. Te & H. Fisch: Cavernous electromyography as an indication of adequate smooth muscle relaxation during penile duplex ultrasonography. 5th World mtg. on Impotence. Milan, Italy, 1992.
A.E. Te, R. Buttyan, H.P. Koo, L. Greene, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophins in the rat penis. 5th World meeting on Impotence. Milan, Italy, 1992.
R. Shabsigh*, A.E. Te, H. Fisch, I.S. Sawczuk & C.A. Olsson: Combined dynamic infusion cavernosometry and cavernosography (DICC) with single potential analysis of cavernous electromyography (SPACE). AUA NY section Annual Mtg., Berlin, Germany, 1992.
A.E. Te, R. Buttyan, H.P. Koo, S.A. Kaplan, C.A. Olsson & R. Shabsigh*: Neurotrophic factors in the diabetic rat penis: an extended study. J. Urol., 149: 247A, Abstract #136, 1993.
H.P. Koo, Richard P. Santarosa, R. Buttyan, R. Shabsigh, C.A. Olsson & S.A. Kaplan: Comparison of gene expression in streptozotocin induced diabetic cystopathy and osmotic diureses in rat bladder. J. Urol., 149: 267A, Abstract #213, 1993.
R.P. Santarosa, A.E. Te, J.P. Koo, R. Buttyan, S.A. Kaplan, C.A. Olsson & R. Shabsigh: Androgen deprivation and apoptosis in the rat erectile tissue. J. Urol., 151: 494A, Abstract #1067,1994.
R.P. Santarosa, A.E. Te, J. Raymond, M. Colombel, C.A. Olsson, R. Buttyan & R. Shabsigh*: Testosterone sensitivity of the erectile tissue of the rat penis to castration. World Meeting on Impotence. Singapore, 9/12-16, 94, ISIR, 1994.
A. Kirsch, M. Miller, J. Connor, T. Hensle & R. Shabsigh*: Tunica albugenia patch grafts, comparison of laser welding versus suturing. World meeting on Impotence. Singapore, 9/12-16, 94, ISIR, 1994.
A. Kirsch, M. Miller, J. Connor, T. Hensle & R. Shabsigh*: Tunica albugenia patch grafts, comparison of laser welding versus suturing. American Academy of Pediatrics. St. Louis, 11, ISIR, 1994.
J. Raymond, R.P. Santarosa, Kathleen M. O'Toole, C.A. Olsson, R. Buttyan & R. Shabsigh*: In-situ localization in the rat penis of DNA synthesis induced by testosterone after castration. J. Urol., 153: 508A, Abstract #1120, 1995.
A. Kirsch, M. Miller, R. Shabsigh, T. Hensle & J. Connor: Urologic reconstruction using the diod laser and human protein solder. J. Urol., 153: 52A, 1995.
L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Apoptosis in the rat penis after denervation. J. Urol., 155: A, 1996.
H. Padma-Nathan, R. Shabsigh, et al: Treatment of erectile dysfunction (impotence) by transurethral Alprostadil. J. Urol., 155: A, 1996.
R.W. Lewis, C.B. Brendler, A.L. Burnett, R.G. Ferrigni, W.G.J. Hellstrom, H. Padma-Nathan, N. Romas, & R. Shabsigh: A comparison of transurethral alprostadil and alprostadil/prazosin combinations for the treatment of erectile dysfunction. J. Urol., 157: 181A, abstract # 703, 1997
L. T. Klein, M. I. Miller, R. Buttyan, A. Raffo, M. Burchardt, G. deVries, C. A. Olsson & R. Shabsigh*: Elevation of vascular endothelial growth factor in the rat penis after denervation. J. Urol., 157: 355A, abstract # 1388, 1997.
R.A. Constable, F.E. Govier, R.G. Ferrigi, K.T.McVary, R. Shabsigh*, K.J. Nemo, P.Y. Tam, & A.P.Spivak: Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy. J. Urol., 157: 364A, abstract # 1424, 1997
R. Shabsigh*: Treatment of erectile dysfunction at the end of the millenium. Internat. J. Impot. Res., 9: S22, 1997.
R. Shabsigh*, L. Klein, S. Seidma, S.A. Kaplan, J. Ritter, B. Lehrhoff: High incidence of depressive symptoms is associated with erectile dysfunction. Internat. J. Impot. Res., 1998.
R. Shabsigh*: Efficacy of Sildenafil is not affected by etiology of erectile dysfunction. Internat. J. Impot. Res., 1998.
R. Shabsigh*, A. Shabsigh, & S. Flanders: Covariates of sexual function and bother in the first 6 months of treatment of prostate cancer with hormonal therapy: results from the CAPSURE database. Internat. J. Impot. Res., 1998.
R. Shabsigh*, H. Padma-Nathan, J. Kaufman, M. Gittelman, & I. Goldstein: Comparative results of efficacy and safety of intracavernous alprostadil alfadex and intraurethral alprostadil. Internat. J. Impot. Res., 1998.
K. Cooper, D. Weiner, V. Staiman, M. Biddelman, S. Seidman, & R. Shabsigh*: Prevalence of sexual dysfunction, urinary symptoms, and depressive symptoms in partners of men with erectile dysfunction. J. Urol., 161, (4), suppl, 270A, abstract # 1044, 1999.
M. Burchardt, T. Burchardt, MW. Chen, A. Shabsigh, A. de La Taille, R. Buttyan, & R. Shabsigh*: Expression of RNA splice variants for VEGF in the adult rat and human penis. J. Urol., 161, (4), suppl, 219A, abstract # 840, 1999.
T. Burchardt, M. Burchardt, L. Baer, R. Pawar, A. Shabsigh, A. de La Taille, O. Hayek, M. Ghafar, & R. Shabsigh*: Sexual dysfunction in female patients with hypertension. J. Urol., 163, (4), suppl, 240A, abstract # 1068, 2000.
H. Padma-Nathan, R. Shabsigh*, R. Weiss, DD. Michie, & R. Rosen: Efficacy and safety of alprostadil (Caverject) in sildenafil (Viagra) failures. J. Urol., 163, (4), suppl, 201A, abstract # 895, 2000.
AG Anastasiadis, AR Davis, M Fleming, L Cushman, D Barsbay, MA Ghafar, IS Sawzcuk, D Droggin, M Burchardt, R Shabsigh: Sexual Functioning among men and women with renal cancer. FSFF, 2001.
H Padma-Nathan, RC Rosen, R Shabsigh, K Saikali, & V Watkins: Cialis (IC351) provides prompt response and extended period of responsiveness for the treatment of men with ED. J. Urol., 165 (5), suppl, 224A, abstract# 923, 2001.
T. Burchardt, M. Burchardt, R Buttyan, A. Shabsigh, A. de La Taille, A Anastasiadis, MA Ghafar, & , R Shabsigh: Reduction in endothelial and smooth muscle density in the corpora cavernosa of the diabetic rat. J. Urol., 165 (5), suppl, 229A, abstract# 945, 2001.
A Anastasiadis, H El-Rashidy, D Droggin, MP Rosenwasser, R Shabsigh & MC Benson: Sural nerve grafts with radical prostatectomy or radical cystectomy. J. Urol., 165 (5), suppl, 229A, abstract# 945, 2001.
R. Shabsigh, JM Kaufman, C. Steidle, & H. Padma-Nathan: Testosterone replacement therapy with testosterone gel 1% converts sildenafil non-responders to responders in men with hypogonadism and ED who failed prior sildenafil alone. J. Urol., 169 (4), suppl, 247, abstract # 954, 2003
M. Burchardt, T. Burchardt, R. Buttyan, AG Anastasiadis, A. De La Taille, A. Shabsigh & R. Shabsigh: Angiogenic factors for therapy of ED: protein and DNA transfer of VEGF in the rat penis. J. Urol., 169 (4), suppl, 247, abstract # 1202, 2003
R Shabsigh, C Brown, JS Fendl, & J Yeager: Treatment of female sexual arousal disorder (FSAD) using a novel topical alsprostadil cream, phase 2 clinical study. J. Urol., 169 (4), suppl, 247, abstract # 1322, 2003
AG Anastasiadis, R Sachdev, L Salomon, MA Ghafar, R Shabsigh & AE Katz: Quality of life after primary or salvage cryotherapy for clinically localized prostate cancer. J. Urol., 169 (4), suppl, 247, abstract # PD23, 2003.
R Shabsigh*, SN Seidman, AR Davis, T Brown, M Miyazaki: The central, acute effect of testosterone in post-menopausal women assessed by fMRI. JSM 2, suppl. abstract, 2004.
R Shabsigh*, AB Araujo, AB O’Donnell, JB McKinlay: Does erectile dysfunction predict risk of metabolic syndrome in aging men? Results from the Massachusetts Male Aging Study. J. Urol., 173 (4), suppl, abstract # 6188, 2005.
R Shabsigh*: Lifetable analysis of antibiotic-coating of inflatable penile prosthesis AMS700 series with rifampicin and minocycline in patients with diabetes. J Urol, 173 (4), suppl, abstract #6192, 2005.

Patents

US patent 6,706,682. March 2004: Use of the vascular endothelial growth factor in the treatment of erectile dysfunction. Inventor: Ridwan Shabsigh, assignment: trustees of Columbia University.

Hobbies & special interests:

Hiking
Photography

Languages:

English
Arabic
Circassian
German
Spanish

return to view all presentations

ISSAM: International Society for the Study of the Aging Male